GLP-1s: From Breakthrough Treatment to Public Health Challenge—Tracing the Journey

Not long ago, the idea of a single drug that could treat obesity, type 2 diabetes, heart disease, fatty liver disease, and even addiction seemed like pure fantasy. A miracle drug? Please. And yet, science delivered. GLP-1 receptor agonists burst…